<VariationArchive RecordType="classified" VariationID="11699" VariationName="NM_005629.4(SLC6A8):c.950dup (p.Tyr317Ter)" VariationType="Duplication" Accession="VCV000011699" Version="4" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-04-09" DateCreated="2013-07-24" MostRecentSubmission="2023-04-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26738" VariationID="11699">
      <GeneList>
        <Gene Symbol="SLC6A8" FullName="solute carrier family 6 member 8" GeneID="6535" HGNC_ID="HGNC:11055" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153687926" stop="153696593" display_start="153687926" display_stop="153696593" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152953751" stop="152962047" display_start="152953751" display_stop="152962047" Strand="+" />
          </Location>
          <OMIM>300036</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC6A8">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005629.4(SLC6A8):c.950dup (p.Tyr317Ter)</Name>
      <CanonicalSPDI>NC_000023.11:153693299:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="153693299" stop="153693300" display_start="153693299" display_stop="153693300" variantLength="1" positionVCF="153693299" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="152958754" stop="152958755" display_start="152958754" display_stop="152958755" variantLength="1" positionVCF="152958754" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <OtherNameList>
        <Name>NM_005629.4(SLC6A8):c.950dup</Name>
        <Name>p.Tyr317Ter</Name>
      </OtherNameList>
      <ProteinChange>Y202*</ProteinChange>
      <ProteinChange>Y317*</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005629.3" sequenceAccession="NM_005629" sequenceVersion="3" change="c.950dupA">
            <Expression>NM_005629.3:c.950dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.152958755dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.152958755dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.153693300dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.153693300dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012016.2" sequenceAccession="NG_012016" sequenceVersion="2" change="g.10004dup">
            <Expression>NG_012016.2:g.10004dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142805.2" sequenceAccession="NM_001142805" sequenceVersion="2" change="c.950dup">
            <Expression>NM_001142805.2:c.950dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136277.1" sequenceAccession="NP_001136277" sequenceVersion="1" change="p.Tyr317Ter">
            <Expression>NP_001136277.1:p.Tyr317Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142806.1" sequenceAccession="NM_001142806" sequenceVersion="1" change="c.605dup">
            <Expression>NM_001142806.1:c.605dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001136278.1" sequenceAccession="NP_001136278" sequenceVersion="1" change="p.Tyr202Ter">
            <Expression>NP_001136278.1:p.Tyr202Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005629.4" sequenceAccession="NM_005629" sequenceVersion="4" change="c.950dup" MANESelect="true">
            <Expression>NM_005629.4:c.950dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005620.1" sequenceAccession="NP_005620" sequenceVersion="1" change="p.Tyr317Ter">
            <Expression>NP_005620.1:p.Tyr317Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005629.4" sequenceAccession="NM_005629" sequenceVersion="4" change="c.950dupA" MANESelect="true">
            <Expression>NM_005629.4:c.950dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300036.0004" DB="OMIM" />
        <XRef Type="rs" ID="1569539359" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005629.4(SLC6A8):c.950dup (p.Tyr317Ter) AND Creatine transporter deficiency" Accession="RCV000012465" Version="18">
        <ClassifiedConditionList TraitSetID="3187">
          <ClassifiedCondition DB="MedGen" ID="C1845862">Creatine transporter deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-02-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-23" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-07-24" MostRecentSubmission="2023-04-09">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/d4d48749-6156-4ccd-b3a5-30e00e62cdf4</URL>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15154114</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3187" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1686" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CREATINE TRANSPORTER DEFECT</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEREBRAL CREATINE DEFICIENCY SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300036.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SLC6A8-Related Creatine Transporter Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Creatine transporter deficiency</ElementValue>
                <XRef ID="MONDO:0010305" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Creatine deficiency, X-linked</ElementValue>
                <XRef ID="Creatine+Deficiency%2C+X-Linked/2001" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked with seizures, short stature and midface hypoplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation , X-linked, with creatine transport deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine transporter deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked creatine deficiency syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCDS1</ElementValue>
                <XRef Type="MIM" ID="300352" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency. Developmental delay and cognitive dysfunction or intellectual disability and speech-language disorder are common to all three CDDs. Onset of clinical manifestations of GAMT deficiency (reported in ~130 individuals) is between ages three months and two years; in addition to developmental delays, the majority of individuals have epilepsy and develop a behavior disorder (e.g., hyperactivity, autism, or self-injurious behavior), and about 30% have movement disorder. AGAT deficiency has been reported in 16 individuals; none have had epilepsy or movement disorders. Clinical findings of CRTR deficiency in affected males (reported in ~130 individuals) in addition to developmental delays include epilepsy (variable seizure types and may be intractable) and behavior disorders (e.g., attention deficit and/or hyperactivity, autistic features, impulsivity, social anxiety), hypotonia, and (less commonly) a movement disorder. Poor weight gain with constipation and prolonged QTc on EKG have been reported. While mild-to-moderate intellectual disability is commonly observed up to age four years, the majority of adult males with CRTR deficiency have been reported to have severe intellectual disability. Females heterozygous for CRTR deficiency are typically either asymptomatic or have mild intellectual disability, although a more severe phenotype resembling the male phenotype has been reported.</Attribute>
                <XRef ID="NBK3794" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1608" />
                <XRef ID="1608" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301745</ID>
                <ID Source="BookShelf">NBK3794</ID>
              </Citation>
              <XRef ID="52503" DB="Orphanet" />
              <XRef ID="C1845862" DB="MedGen" />
              <XRef ID="MONDO:0010305" DB="MONDO" />
              <XRef Type="MIM" ID="300352" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32699" SubmissionDate="2013-07-17" DateLastUpdated="2013-07-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300036.0004_CEREBRAL CREATINE DEFICIENCY SYNDROME 1" title="SLC6A8, 1-BP INS, 950A_CEREBRAL CREATINE DEFICIENCY SYNDROME 1" />
        <ClinVarAccession Accession="SCV000032699" DateUpdated="2013-07-24" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2004-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In the index patient of a family with X-linked mental retardation, due to a defect in creatine metabolism (300352), Rosenberg et al. (2004) found an insertion of adenosine at cDNA position 950 in exon 6 of the SLC6A8 gene (950_951insA), resulting in a premature stop (tyr317 to stop, Y317X). The truncated mutant protein was predicted to lack 319 C-terminal residues, including transmembrane domains VII through XII, and to be unstable and/or inappropriately folded and therefore completely inactive.</Attribute>
              <Citation>
                <ID Source="PubMed">15154114</ID>
              </Citation>
              <XRef DB="OMIM" ID="300352" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <Name>SLC6A8, 1-BP INS, 950A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 950A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300036.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEREBRAL CREATINE DEFICIENCY SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5002685" SubmissionDate="2022-12-11" DateLastUpdated="2022-12-17" DateCreated="2022-08-08">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_genetics_wch9/vc31913" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002556731" DateUpdated="2022-12-17" DateCreated="2022-08-08" Type="SCV" Version="2" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" OrgAbbreviation="GMP-FMC" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_14347</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005629.4:c.950dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300352" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_36</SubmissionName>
          <SubmissionName>submission_33</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7195919" SubmissionDate="2023-03-29" DateLastUpdated="2023-04-09" DateCreated="2023-04-09">
        <ClinVarSubmissionID localKey="d4d48749-6156-4ccd-b3a5-30e00e62cdf4" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003852679" DateUpdated="2023-04-09" DateCreated="2023-04-09" Type="SCV" Version="1" SubmitterName="ClinGen Cerebral Creatine Deficiency Syndromes Variant Curation Expert Panel, ClinGen" OrgID="508816" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-23">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/d4d48749-6156-4ccd-b3a5-30e00e62cdf4</URL>
          </Citation>
          <Comment>The NM_005629.4(SLC6A8):c.950dup (p.Tyr317Ter) variant in SLC6A8 is predicted to cause a premature stop codon in biologically-relevant-exon 6/13, leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). This is supported by failure of the variant to restore creatine uptake when it was transiently expressed in SLC6A8-deficient fibroblasts (PMID: 7465020). The variant is absent in gnomAD v2.1.1 (PM2_Supporting). The variant has been reported in a patient with X-linked disability (PMID 15154114). However, results of urine creatine measurement and cerebral creatine level from brain proton-MRS were not provided. There is a ClinVar entry for this variant (Variation ID: 11699). In summary, this variant meets the criteria to be classified as likely pathogenic for creatine transporter deficiency. The classification of this variant has been upgraded to pathogenic based on the availability of functional data (included as PVS1_observed) and the report of the variant in an individual with clinical features consistent with creatine transporter deficiency with insufficient data to apply PP4. SLC6A8-specific ACMG-AMP criteria applied, as specified by the ClinGen CCDS VCEP (Specification Version 1.1.0): PVS1, PM2_Supporting. (Classification approved by the ClinGen CCDS VCEP on February 23, 2023).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen_CCDS_ACMG_Specifications_SLC6A8_v1.1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/qrdrqmt7/clingen_ccds_acmg_specifications_slc6a8_v1.1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC6A8" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_005629.4(SLC6A8):c.950dup</Name>
            <Name>p.Tyr317Ter</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.11:g.153693300dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0010305" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13004156</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5002685" TraitType="Disease" MappingType="XRef" MappingValue="300352" MappingRef="OMIM">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32699" TraitType="Disease" MappingType="Name" MappingValue="CEREBRAL CREATINE DEFICIENCY SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7195919" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0010305" MappingRef="MONDO">
        <MedGen CUI="C1845862" Name="Creatine transporter deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

